Quantifying the Prevalence and Phenotypic Consequences of Transcriptional Irreversibility in Bacteria

NSF Award Search · 01002526DB NSF RESEARCH & RELATED ACTIVIT · $1,093,791 · view on nsf.gov ↗

Abstract

A key question in biology is how genetically identical cells achieve varied appearances and behaviors. These distinct cell states are realized by variations in gene expression within certain cells in the population; different genes are turned “on” or “off” in these cells. These variations in gene expression can lead to different phenotypes within a population of genetically identical cells. For example, variations in gene expression can lead some cells in a population of genetically identical bacteria to become antibiotic tolerant while other cells in the population remain suspectable to antibiotics. This project will address how variations in gene expression lead to important phenotypic changes in bacteria. To complement the research, an interactive series of lessons on mathematics in biology will be developed for high school students. These lessons will be distributed through a series of teacher workshops. Irreversibility, hysteresis, and multistability in cell state have been quantitatively studied in a handful of specific bacterial systems — B. subtilis sporulation, the lac repressor, and the lysis-lysogeny switch are now classic examples. Here, the investigators seek to expand the understanding of these concepts to the genomic scale: the investigators will examine the time scales of reversibility, and the prevalence of irreversibility, following transient repression of all genes with known function in E. coli. To accomplish this, the investigators will develop a new r

Key facts

NSF award ID
2624903
Awardee
Johns Hopkins University (MD)
SAM.gov UEI
FTMTDMBR29C7
PI
Kimberly A Reynolds
Primary program
01002526DB NSF RESEARCH & RELATED ACTIVIT
All programs
NANOSCALE BIO CORE, ELEMENTARY/SECONDARY EDUCATION, UNDERGRADUATE EDUCATION, GRADUATE INVOLVEMENT
Estimated total
$1,093,791
Funds obligated
$337,841
Transaction type
Continuing Grant
Period
10/01/2025 → 01/31/2027